Provided by Tiger Trade Technology Pte. Ltd.

Alvotech

3.53
-0.0500-1.40%
Post-market: 3.530.00000.00%16:10 EDT
Volume:1.26M
Turnover:4.47M
Market Cap:1.10B
PE:14.70
High:3.62
Open:3.57
Low:3.44
Close:3.58
52wk High:11.85
52wk Low:3.42
Shares:313.00M
Float Shares:116.17M
Volume Ratio:2.06
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2402
EPS(LYR):-0.8654
ROE:--
ROA:3.61%
PB:-3.88
PE(LYR):-4.08

Loading ...

Nordic Stocks Decline; Alvotech SDR Takes Biggest Hit

Dow Jones
·
Dec 02, 2025

BUZZ-India's Dr Reddy's rises after EU marketing authorisation for osteoporosis biosimilar

Reuters
·
Nov 25, 2025

Alvotech Wins EU Approval for Osteoporosis, Cancer Bone Treatment Biosimilar

MT Newswires Live
·
Nov 24, 2025

BRIEF-Alvotech Gets Approval Of Avt03 In European Economic Area

Reuters
·
Nov 24, 2025

Alvotech SA Wins European Approval for AVT03, Biosimilar to Prolia and Xgeva

Reuters
·
Nov 24, 2025

Alvotech Announces Approval of Avt03, a Biosimilar to Prolia® and Xgeva® (Denosumab) in the European Economic Area

THOMSON REUTERS
·
Nov 24, 2025

Alvotech and Advanz Pharma Secure EC Approval for Gobivaz Biosimilar to Simponi

Reuters
·
Nov 20, 2025

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (Golimumab)

THOMSON REUTERS
·
Nov 20, 2025

Alvotech SA Revises 2025 Revenue Outlook To $570-$600 Million

Reuters
·
Nov 20, 2025

Alvotech Is Maintained at Buy by UBS

Dow Jones
·
Nov 19, 2025

Nordic Shares Decline; Alvotech Falls Furthest

Dow Jones
·
Nov 19, 2025

UBS Adjusts Alvotech Price Target to $10 From $13, Maintains Buy Rating

MT Newswires Live
·
Nov 19, 2025

Alvotech price target lowered to $10 from $13 at UBS

TIPRANKS
·
Nov 18, 2025

Alvotech (ALVO) Receives a Buy from Northland Securities

TIPRANKS
·
Nov 14, 2025

Alvotech Reports Strong Turnaround in Financial Performance

TIPRANKS
·
Nov 14, 2025

Stock Track | Alvotech Plunges 8.39% in Pre-market Following Q3 Miss and Ongoing Challenges

Stock Track
·
Nov 13, 2025

Stock Track | Alvotech Plunges 8.39% in Pre-market Following Q3 Disappointment and Ongoing Concerns

Stock Track
·
Nov 13, 2025

Stock Track | Alvotech Shares Plummet 7.68% After Q3 Revenue Miss and Lowered Guidance

Stock Track
·
Nov 13, 2025

Stock Track | Alvotech Plunges 7.68% After Q3 Revenue Miss and Lowered Guidance Amid FDA Concerns

Stock Track
·
Nov 13, 2025

UK High Court Supports Alvotech’s Biosimilar Launch Plans

TIPRANKS
·
Nov 13, 2025